Large-scale testing (Phase 3)Ended earlyNCT00723411
What this trial is testing
A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Therapeutics AB 334